Maillet EL

Eleusis Therapeutics US, New York, NY, USA.

2 papers · ORCID

ArticleLSD

Safety, tolerability, pharmacokinetics, and subjective effects of 50, 75, and 100 µg LSD in healthy participants within a novel intervention paradigm: A proof-of-concept study.

Family N, Hendricks PS, Williams LT +4

Europe PMC2022
ArticleLSD

Safety, tolerability, pharmacokinetics, and pharmacodynamics of low dose lysergic acid diethylamide (LSD) in healthy older volunteers.

Family N, Maillet EL, Williams LTJ +6

Europe PMC2020